• Facebook
  • Twitter
Cancer World Archive
  • Magazine
Home2011October

October 2011

Securing quality cancer care: Governments must step up to the plat

Number 44

Editorial 1 October 2011 0

The OECD recently made a cross-country analysis of how cancer care systems work in an attempt to explain variations in cancer survival in Europe.

Julio Celis: bridging science and politics

Number 44

Cover Story 1 October 2011 0

Julio Celis, a scientist to his core, has arguably had the greatest impact in helping shape the structures of Europe’s cancer research effort. Download full article

No Picture

State-of-the-art treatment for advanced melanoma

Number 44

Grandround 1 October 2011 0

Progress in treating melanoma has lagged behind many other cancers for decades. But a number of novel approaches are now offering a glimmer of hope. Download full article

The future of cancer, as told through the story of Renee

Number 44

Spotlight on 1 October 2011 0

Explaining the science which offers new hope to cancer patients. Download full article

The ESO Masterclass: where those most eager to learn meet those most willing to teach

Number 44

Spotlight on 1 October 2011 0

The annual week-long course lies at the very heart of ESO’s mission and shapes the oncology leaders of tomorrow. Download full article

A minimum acceptable standard of care for every patient

Number 44

Systems & Services 1 October 2011 0

How can we transmit knowledge about cancer patients’ needs to the people who have the power to act, in a way they can quickly and easily understand? Download full article

No Picture

Denosumab – a new option for solid tumours metastatic to bone

Number 44

Impact Factor 1 October 2011 0

Zoledronic acid is a potent bisphosphonate used as the standard therapy for the prevention of skeletal-related events in patients with solid tumours metastatic to bone. Three phase III studies have reported head-to-head comparisons of zoledronic [more]

No Picture

Perioperative therapy improves gastro-oesophageal cancer survival

Number 44

Impact Factor 1 October 2011 0

A randomised phase III study has reported significant improvements in RO resection rate and overall survival associated with perioperative cisplatin and 5-fluorouracil treatment compared with surgery alone in patients with gastro-oesophageal adenocarcinoma. These data support [more]

No Picture

Newsround

Number 44

Spotlight on 1 October 2011 0

Cancer family histories found to be inaccurate Download full article

LATEST PRINTED ISSUE

Latest news

  • Four steps to eliminating HPV infections across Europe: an ECCO call for EU action

    News 16 October 2020 0
    A new report underlines that vaccination, screening, treatment and public awareness, provide the cornerstone for eliminating human papillomavirus (HPV) in Europe. The report was published by The European [more]

Facebook

Twitter

Tweet di @CancerworldESO

© Copyright ESO 2018 with all rights reserved - Credits -


Privacy Policy Cookie Policy